TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• TP53 truncating mutations are frequent in human cancers, typically leading to a loss of p53 tumor suppressor function.
• The functional consequences of specific TP53 mutations, such as those in exon 6, are not fully understood.

Purpose of the Study:

• To investigate the frequency and functional impact of TP53 exon-6 truncating mutations.
• To elucidate the molecular mechanisms by which these mutants promote tumorigenesis.

Main Methods:

• Analysis of TP53 mutation frequencies in cancer datasets.
• Functional assays to assess p53 mutant protein activity, localization, and interaction with Cyclophilin D (CypD).

Main Results:

• TP53 exon-6 truncating mutations occur more frequently than expected and produce proteins with novel oncogenic functions.
• These p53 mutants promote cancer cell proliferation, survival, and metastasis by activating mitochondrial Cyclophilin D.
• The mutant p53 proteins function similarly to the p53-psi splice variant.

Conclusions:

• TP53 exon-6 truncating mutations contribute to tumorigenesis through mechanisms beyond simple p53 loss of function.
• Targeting the mitochondrial pathway activated by these mutant p53 proteins may offer new therapeutic strategies for relevant cancers.